Formulation Development White Papers & Articles
-
Developing More Clinically Relevant Drug-Induced Thrombosis Models
4/9/2024
Learn how this Blood Vessel-Chip is capable of replicating drug side effects and mimicking the human circulatory system accurately, enhancing drug safety and efficacy in development.
-
Boosting In Vitro Toxicology Testing With Organ-Chips
4/9/2024
Discover how Organ-Chips are enhancing preclinical testing, minimizing toxicity issues, and streamlining clinical trials for enhanced safety and efficiency.
-
Advancing 3D Cell Culture Models For Clinical Relevance
4/9/2024
Concerns about in vitro relevance and animal study limits have advanced cell culture tech. Explore how Organ-Chips offer a refined approach to studying human physiology.
-
Organ-Chips: A Promising Model For Human Emulation
4/9/2024
Organ-Chips offer more accurate assessments of safety and efficacy readouts compared to other cell and animal models used by academia, government, and pharmaceutical entities to study drug toxicity.
-
Advances In Developing In Vitro Models Of Neurodegenerative Diseases
4/9/2024
Discover a more predictive in vitro model of the human brain that represents the next step in predictive biological models for neurodegenerative disease research.
-
The Technology Improving Inflammatory Disease Drug Development
4/9/2024
Learn about the global health burden of inflammatory disease, challenges associated with modeling inflammatory disease, and the future of inflammatory disease research.
-
Top Challenges In Recombinant Protein Purification Process Development
3/27/2024
Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.
-
Three Key Considerations For Optimizing Process Development
3/21/2024
When it comes to process development, timing, technology, and partners all merit careful consideration. Explore expert insights into these three crucial factors.
-
Navigating Cell Therapy Process Development
3/21/2024
Explore the main challenges and considerations inherent in cell therapy process development.
-
Biopharma Resilience: Mass Immunization Programs
3/18/2024
Explore the challenges involved with mass immunization programs, what role government can play in facilitating vaccination programs, how technology is transforming the biopharma industry, and more.